COPD: open trials in Chile

• NCT06959095

  Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

  Trial Treatment · Phase 3 · GlaxoSmithKline

  GSK Investigational Site, Curicó

  Registry updated 2026-10-05

• NCT06283966

  A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

  Trial Treatment · Phase 3 · AstraZeneca

  Research Site, Curicó · Research Site, Quillota · Research Site, Santiago · Research Site, Talca · Research Site, Temuco · Research Site, Victoria · Research Site, Viña del Mar · Research Site, Vitacura

  Registry updated 2026-10-02

• NCT06883305

  A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

  Trial Treatment · Phase 3 · AstraZeneca

  Research Site, Chile · Research Site, Concepción · Research Site, Curicó · Research Site, Quillota · Research Site, Santiago · Research Site, Talca

  Registry updated 2026-09-03

All COPD trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error